Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Cantor Fitzgerald
Johnson and Johnson
Colorcon
US Department of Justice
Novartis
Healthtrust
Federal Trade Commission
Cerilliant

Generated: February 21, 2018

DrugPatentWatch Database Preview

Doxorubicin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for doxorubicin hydrochloride and what is the scope of doxorubicin hydrochloride freedom to operate?

Doxorubicin hydrochloride
is the generic ingredient in five branded drugs marketed by Janssen Res And Dev, Dr Reddys Labs Ltd, Sun Pharma Global, Pharmacia And Upjohn, Actavis Inc, Alvogen Inc, Amneal Pharms Co, Fresenius Kabi Usa, Gland Pharma Ltd, Mylan Labs Ltd, Pharmachemie Bv, Sagent Pharms, Sandoz Inc, Sun Pharm Inds, Teva Pharms Usa, West-ward Pharms Int, and Bristol Myers Squibb, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for doxorubicin hydrochloride. Seventeen suppliers are listed for this compound.
Pharmacology for doxorubicin hydrochloride
Medical Subject Heading (MeSH) Categories for doxorubicin hydrochloride

US Patents and Regulatory Information for doxorubicin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb RUBEX doxorubicin hydrochloride INJECTABLE;INJECTION 062926-001 Apr 13, 1989 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 062921-003 Mar 17, 1989 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 200170-002 Oct 28, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 091418-001 Feb 15, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 050467-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 064097-001 Sep 13, 1994 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 062921-001 Mar 17, 1989 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 208657-002 May 15, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 200901-001 Feb 14, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 200146-001 Jul 18, 2012 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for doxorubicin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Res And Dev DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-001 Nov 17, 1995 ➤ Sign Up ➤ Sign Up
Janssen Res And Dev DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-002 Jun 13, 2000 ➤ Sign Up ➤ Sign Up
Janssen Res And Dev DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-001 Nov 17, 1995 ➤ Sign Up ➤ Sign Up
Janssen Res And Dev DOXIL (LIPOSOMAL) doxorubicin hydrochloride INJECTABLE, LIPOSOMAL;INJECTION 050718-002 Jun 13, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Colorcon
Mallinckrodt
Covington
Express Scripts
Chubb
UBS
Daiichi Sankyo
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot